22nd Century Current Ratio 2011-2024 | XXII
22nd Century current ratio from 2011 to 2024. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
| 22nd Century Current Ratio Historical Data |
| Date |
Current Assets |
Current Liabilities |
Current Ratio |
| 2024-06-30 |
$0.01B |
$0.02B |
0.84 |
| 2024-03-31 |
$0.01B |
$0.03B |
0.54 |
| 2023-12-31 |
$0.02B |
$0.03B |
0.65 |
| 2023-09-30 |
$0.04B |
$0.04B |
1.02 |
| 2023-06-30 |
$0.04B |
$0.03B |
1.47 |
| 2023-03-31 |
$0.04B |
$0.02B |
2.44 |
| 2022-12-31 |
$0.05B |
$0.01B |
3.43 |
| 2022-09-30 |
$0.06B |
$0.02B |
3.45 |
| 2022-06-30 |
$0.05B |
$0.02B |
2.47 |
| 2022-03-31 |
$0.05B |
$0.01B |
6.26 |
| 2021-12-31 |
$0.05B |
$0.01B |
6.45 |
| 2021-09-30 |
$0.06B |
$0.01B |
8.93 |
| 2021-06-30 |
$0.07B |
$0.01B |
7.65 |
| 2021-03-31 |
$0.04B |
$0.01B |
5.20 |
| 2020-12-31 |
$0.03B |
$0.01B |
3.86 |
| 2020-09-30 |
$0.03B |
$0.01B |
5.06 |
| 2020-06-30 |
$0.04B |
$0.01B |
5.74 |
| 2020-03-31 |
$0.04B |
$0.01B |
7.65 |
| 2019-12-31 |
$0.04B |
$0.01B |
7.39 |
| 2019-09-30 |
$0.05B |
$0.01B |
9.50 |
| 2019-06-30 |
$0.05B |
$0.01B |
7.25 |
| 2019-03-31 |
$0.06B |
$0.01B |
9.26 |
| 2018-12-31 |
$0.06B |
$0.01B |
11.83 |
| 2018-09-30 |
$0.07B |
$0.01B |
10.20 |
| 2018-06-30 |
$0.06B |
$0.01B |
10.21 |
| 2018-03-31 |
$0.06B |
$0.01B |
12.52 |
| 2017-12-31 |
$0.07B |
$0.00B |
15.68 |
| 2017-09-30 |
$0.02B |
$0.00B |
5.70 |
| 2017-06-30 |
$0.02B |
$0.00B |
4.41 |
| 2017-03-31 |
$0.01B |
$0.00B |
4.15 |
| 2016-12-31 |
$0.02B |
$0.00B |
5.17 |
| 2016-09-30 |
$0.01B |
$0.00B |
2.90 |
| 2016-06-30 |
$0.01B |
$0.00B |
2.06 |
| 2016-03-31 |
$0.01B |
$0.00B |
2.76 |
| 2015-12-31 |
$0.01B |
$0.00B |
2.23 |
| 2015-09-30 |
$0.01B |
$0.00B |
3.20 |
| 2015-06-30 |
$0.01B |
$0.00B |
4.14 |
| 2015-03-31 |
$0.01B |
$0.00B |
2.91 |
| 2014-12-31 |
$0.01B |
$0.00B |
4.01 |
| 2014-09-30 |
$0.02B |
$0.00B |
6.43 |
| 2014-06-30 |
$0.01B |
$0.00B |
3.98 |
| 2014-03-31 |
$0.01B |
$0.00B |
6.37 |
| 2013-12-31 |
$0.01B |
$0.00B |
7.87 |
| 2013-09-30 |
$0.00B |
$0.00B |
1.09 |
| 2013-06-30 |
$0.00B |
$0.00B |
0.79 |
| 2013-03-31 |
$0.00B |
$0.00B |
0.86 |
| 2012-12-31 |
$0.00B |
$0.01B |
0.28 |
| 2012-09-30 |
$0.00B |
$0.00B |
0.28 |
| 2012-06-30 |
$0.00B |
$0.00B |
0.36 |
| 2012-03-31 |
$0.00B |
$0.00B |
0.29 |
| 2011-12-31 |
$0.00B |
$0.00B |
0.34 |
| 2011-09-30 |
$0.00B |
$0.00B |
0.38 |
| 2011-06-30 |
$0.00B |
$0.00B |
0.73 |
| 2011-03-31 |
$0.00B |
$0.00B |
1.35 |
| 2010-12-31 |
$0.00B |
$0.01B |
0.15 |
| Sector |
Industry |
Market Cap |
Revenue |
| Consumer Staples |
Tobacco Products |
$0.003B |
$0.032B |
|
22nd Century Group, Inc. is a plant biotechnology company focused on decreasing/increasing the level of nicotine in the tobacco plant through genetic engineering and breeding. The Company is focused on development of smoking cessation aid and owns and controls several patents. The company's products include X-22, a prescription smoking cessation aid, which is a tobacco-based botanical medical product for use as a smoking cessation therapy. 22nd Century Group, Inc. is based in Williamsville, New York.
|
